Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2011 Mar 29;20(6):1078–1088. doi: 10.1158/1055-9965.EPI-10-1214

Table 2.

Table of variant–specific summaries: variant name (columns 1 and 5), prior classification (columns 2 and 6), posterior probability that the variant is protein damaging (columns 3 and 7) and natural logarithm of the posterior odds in favor of the variant being protein damaging (columns 4 and 8).

Variant Classification Posterior Probability Damaging loge Posterior Odds Variant Classification Posterior Probability Damaging loge Posterior Odds
5673insC Pathogenic 1.0000 M1783L VUS 0.0013 -6.63
del17/18 Pathogenic 1.0000 M1783T VUS 0.0346 -3.33
W1837X Pathogenic 1.0000 P1614S VUS0.0001 0.0011 -6.82
WT Neutral 0.0000 P1771L VUS 0.0066 -5.01
Y1853X Pathogenic 1.0000 P1806A VUS 0.0016 -6.45
A1669S VUS 0.0625 -2.71 P1812A VUS 0.0050 -5.29
A1708E VUS 1.0000 17.67 P1859R VUS0.0001 0.0013 -6.64
A1752P VUS 1.0000 18.02 Q1785H VUS 0.0012 -6.77
A1823T VUS 0.9999 8.89 Q1826H VUS 0.0031 -5.77
A1830T VUS 0.0015 -6.53 R1443G VUS 0.0223 -3.78
C1697R VUS 0.9999 9.50 R1495M VUS 0.0019 -6.24
D1546N VUS 0.0015 -6.51 R1699L VUS 1.0000 17.50
D1692N VUS 0.0948 -2.26 R1699Q VUS 0.9987 6.65
E1644G VUS 0.0016 -6.45 R1699W VUS 0.8795 1.99
E1794D VUS 0.0013 -6.62 R1726G VUS 0.0013 -6.66
F1662S VUS0.0001* 0.0017 -6.40 R1751P VUS 1.0000 17.54
F1695L VUS 0.0013 -6.63 R1751Q VUS0.0001 0.0022 -6.11
G1706A VUS 1.0000 11.85 R1753T VUS 1.0000 17.57
G1706E VUS0.999 1.0000 16.61 R1835Q VUS 0.0021 -6.15
G1738E VUS 0.9952 5.34 S1512I VUS0.0001 0.0013 -6.62
G1738R VUS0.99 1.0000 17.39 S1613C VUS 0.0012 -6.69
G1788D VUS 0.0147 -4.21 S1613G VUS0.0001 0.0009 -7.03
G1788V VUS 1.0000 17.80 S1655F VUS 0.9995 7.56
H1402Y VUS 0.0032 -5.73 S1715N VUS 0.9994 7.49
H1421Y VUS 0.0017 -6.37 S1715R VUS 0.9997 8.16
H1746N VUS 0.0231 -3.74 T1685I VUS0.99 1.0000 18.59
I1766S VUS 1.0000 16.01 T1700A VUS 0.4291 -0.29
K1487R VUS 0.0045 -5.39 T1720A VUS0.0001 0.0014 -6.59
K1847R VUS 0.0025 -5.98 V1534M VUS0.0001 0.0011 -6.81
L1407P VUS 0.4052 -0.38 V1665M VUS 0.0263 -3.61
L1564P VUS 0.0058 -5.14 V1688del VUS0.99 0.9995 7.60
L1664P VUS 0.0017 -6.38 V1713A VUS 1.0000 14.52
L1764P VUS0.99 1.0000 16.85 V1736A VUS 0.9998 8.69
L1844R VUS 0.0013 -6.62 V1741G VUS 0.7891 1.32
M1628T VUS 0.0031 -5.77 V1804D VUS0.0001 0.0057 -5.17
M1628V VUS 0.0031 -5.78 V1809F VUS 1.0000 17.74
M1628V+S1613G VUS 0.0026 -5.97 V1833M VUS 0.0017 -6.36
M1652I VUS 0.0013 -6.63 W1837R VUS 1.0000 16.96
M1689R VUS 1.0000 16.00 WTdelta14 VUS 0.0013 -6.67
M1775K VUS 1.0000 13.37 WTdelta14+S1616G VUS 0.0012 -6.74
M1775R VUS0.99 1.0000 17.24

The posterior odds are equivalent to the Bayes Factor, Pr(Data ∣ Damaging)/Pr(Data ∣ Benign), because the prior distribution is uniform, and could be combined in this form with other conditionally independent data types.

Known pathogenic variant (“negative control”).

Wild–type, known benign variant (“positive control”).

*

Variant of unknown significance (VUS) previously classified as neutral with an estimated posterior probability of pathogenicity less than 0.0001, but blinded for purposes of model evaluation.

VUS previously classified as pathogenic with an estimated posterior probability greater than 0.999, but blinded for purposes of model evaluation.

VUS previously classified as pathogenic with an estimated posterior probability of between 0.99 and 0.999, but blinded for purposes of model evaluation.